References - Therapeutic Strategies in Cancer Biology and Pathology - page 237

Okumura, H., Kita, Y., Yokomakura, N., Uchikado, Y., Setoyama, T., Sakurai, H., et al., 2010.
Nuclear expression of 14-3-3 sigma is related to prognosis in patients with esophageal
squamous cell carcinoma. Anticancer Res. 30, 5175-5179.
Olbrich, T., Ziegler, E., Tuerk, G., Schubert, A., Emons, G., Gruendker, C., 2010.
Kisspeptin-10 inhibits bone-directed migration of GPR54-positive breast cancer cells:
evidence for a dose-window effect. Gynecol. Oncol. 119, 571-578.
Onori, P., DeMorrow, S., Gaudio, E., Franchitto, A., Mancinelli, R., Venter, J., et al., 2009.
Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of
NF-kappa B and induction of apoptosis. Int. J. Cancer 125, 565-576.
Osada, T., Chen, M., Yang, X.Y., Spasojevic, I., Vandeusen, J.B., Hsu, D., et al., 2011.
Antihelminth compound Niclosamide downregulates Wnt signaling and elicits antitumor
responses in tumors with activating APC mutations. Cancer Res. 71, 4172-4182.
Osoegawa, A., Kometani, T., Nosaki, K., Ondo, K., Hamatake, M., Hirai, F., et al., 2011.
LKB1 mutations frequently detected in mucinous bronchioloalveolar carcinoma. Jpn. J.
Clin. Oncol. 41, 1132-1137.
Ou, W., Ye, S., Yang, W., Wang, Y., Ma, Q., Yu, C., et al., 2012. Enhanced antitumor effect
of cisplatin in human NSCLC cells by tumor suppressor LKB1. Cancer Gene. Ther. 19,
489-498.
Ouatas, T., Halverson, D., Steeg, P.S., 2003. Dexamethasone and medroxyprogesterone acetate
elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast car-
cinoma cells: new uses for old compounds. Clin. Cancer Res. 9, 3763-3772.
Pahl, H.L., 1999. Activators and target genes of Rel/ NF-κB transcription factor. Oncogene 18,
6853-6866.
Palamarchuk, A., Efanov, A., Maximov, V., Aqeilan, R.I., Croce, C.M., Pekarsky, Y., 2005.
Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res. 65,
11282-11286.
Palmieri, D., Halverson, D.O., Ouatas, T., Horak, C.E., Salerno, M., Johnson, J., et al., 2005.
Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in
hormone receptor-negative breast cancer. J. Natl. Cancer Inst. 97, 632-642.
Palmieri, D., Horak, C.E., Lee, J.H., Halverson, D.O., Steeg, P.S., 2006. Translational
approaches using metastasis suppressor genes. J. Bioenergy Biomembr. 38, 151-161.
Pan, S., Wu, X., Jiang, J., Gao, W., Wan, Y., Cheng, D., et al., 2010. Discovery of NVP-LDE225,
a potent and selective smoothened antagonist. ACS Med. Chem. Lett. 1, 130-134.
Pandey, D.P., Picard, D., 2009. miR-22 inhibits estrogen signaling by directly targeting the
estrogen receptor alpha mRNA. Mol. Cell. Biol. 29 (13), 3783-3790.
Pandit, K.V., Corcoran, D., Yousef, H., Yarlagadda, M., Tzouvelekis, A., Gibson, K.F., et al.,
2010. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit.
Care Med. 182, 220-229.
Pang, S.T., Hsieh, W.C., Chuang, C.K., Chao, C.H., Weng, W.H., Juang, H.H., 2009.
Thioredoxin-interacting protein: an oxidative stress-related gene is upregulated by glu-
cose in human prostate carcinoma cells. J. Mol. Endocrinol. 42, 205-214.
Pannifer, A.D., Wong, T.Y., Schwarzenbacher, R., Renatus, M., Petosa, C., Bienkowska, J.,
et al., 2001. Crystal structure of the anthrax lethal factor. Nature 414, 229-233.
Pantuck, A.J., Zeng, G., Belldegrun, A.S., Figlin, R.A., 2003. Pathobiology, prognosis, and
targeted therapy for renal cell carcinoma. Exploiting the hypoxia-induced pathway. Clin.
Cancer Res. 9, 4641-4652.
Park, J., Kang, S.I., Lee, S.Y., Zhang, X.F., Kim, M.S., Beers, L.F., et al., 2010. Tumor sup-
pressor Ras association domain family 5 (RASSF5/NORE1) mediates death receptor
ligand-induced apoptosis. J. Biol. Chem. 285, 35029-35038.